Aryl Hydrocarbon Receptor–Interacting Protein (AIP) N-Terminus Gene Mutations Identified in Pituitary Adenoma Patients Alter Protein Stability and Function

AIP augments CARMA1-BCL10-MALT1 complex formation to facilitate NF-κB signaling upon T cell activation

(2014) Gisela Schimmack et al.   Cell Communication and Signaling

The R304X mutation of the aryl hydrocarbon receptor interacting protein gene in familial isolated pituitary adenomas: Mutational hot-spot or founder effect?

(2014) G. Occhi et al.   JOURNAL OF ENDOCRINOLOGICAL INVESTIGATION

The FKBP-Type Domain of the Human Aryl Hydrocarbon Receptor-Interacting Protein Reveals an Unusual Hsp90 Interaction

(2013) Miriam Linnert et al.   BIOCHEMISTRY

Familial Isolated Pituitary Adenomas (FIPA) and the Pituitary Adenoma Predisposition due to Mutations in the Aryl Hydrocarbon Receptor Interacting Protein (AIP) Gene

(2013) Albert Beckers et al.   ENDOCRINE REVIEWS

Aip regulates cAMP signalling and GH secretion in GH3 cells

(2013) R Formosa et al.   ENDOCRINE-RELATED CANCER

The Aryl Hydrocarbon Receptor Complex and the Control of Gene Expression

(2012) Timothy V. Beischlag et al.   CRITICAL REVIEWS IN EUKARYOTIC GENE EXPRESSION

Germline AIP Mutations in Apparently Sporadic Pituitary Adenomas: Prevalence in a Prospective Single-Center Cohort of 443 Patients

(2012) Laure Cazabat et al.   JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM

Cyclic AMP enhances Smad-mediated BMP signaling through PKA-CREB pathway

(2011) Yoichi Ohta et al.   JOURNAL OF BONE AND MINERAL METABOLISM

AIP and its interacting partners

(2011) Giampaolo Trivellin et al.   JOURNAL OF ENDOCRINOLOGY

Smad-Dependent and Smad-Independent Induction of Id1 by Prostacyclin Analogues Inhibits Proliferation of Pulmonary Artery Smooth Muscle Cells In Vitro and In Vivo

(2010) Jun Yang et al.   CIRCULATION RESEARCH

The role of germlineAIP,MEN1, PRKAR1A,CDKN1BandCDKN2Cmutations in causing pituitary adenomas in a large cohort of children, adolescents, and patients with genetic syndromes

(2010) CA Stratakis et al.   CLINICAL GENETICS

Characterization of aryl hydrocarbon receptor interacting protein (AIP) mutations in familial isolated pituitary adenoma families

(2010) Susana Igreja et al.   HUMAN MUTATION

Clinical Characteristics and Therapeutic Responses in Patients with Germ-LineAIPMutations and Pituitary Adenomas: An International Collaborative Study

(2010) Adrian F. Daly et al.   JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM

G-protein signalling negatively regulates the stability of aryl hydrocarbon receptor

(2009) Asuka Nakata et al.   EMBO REPORTS

The Tyrosine Kinase Receptor RET Interactsin Vivowith Aryl Hydrocarbon Receptor-Interacting Protein to Alter Survivin Availability

(2009) Manuela Vargiolu et al.   JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM

Aryl Hydrocarbon Receptor Interacting Protein Gene (AIP) Mutations are Rare in Patients with Hormone Secreting or Non-secreting Pituitary Adenomas

(2008) S. Buchbinder et al.   EXPERIMENTAL AND CLINICAL ENDOCRINOLOGY & DIABETES

The Role of the Aryl Hydrocarbon Receptor-Interacting Protein Gene in Familial and Sporadic Pituitary Adenomas

(2008) Chrysanthia A. Leontiou et al.   JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM

Lyl1 interacts with CREB1 and alters expression of CREB1 target genes

(2007) Serban San-Marina et al.   BIOCHIMICA ET BIOPHYSICA ACTA-MOLECULAR CELL RESEARCH